Recombinant Yersinia pestis NADH-quinone oxidoreductase subunit A (nuoA)

Basic Research Questions

• What is the function of NADH-quinone oxidoreductase subunit A (nuoA) in Yersinia pestis metabolism?

  NADH-quinone oxidoreductase subunit A (nuoA) is a critical component of the NADH dehydrogenase I complex (NDH-1) in Y. pestis, functioning with EC number 1.6.99.5. This membrane-associated protein participates in the respiratory electron transport chain, coupling the transfer of electrons from NADH to quinones with proton translocation across the membrane. As Y. pestis is classified as a facultative anaerobe (able to grow with or without free oxygen), nuoA plays an essential role in energy metabolism under aerobic conditions . The protein consists of 166 amino acids and contains multiple membrane-spanning domains typical of respiratory complex subunits .

• How is recombinant Y. pestis nuoA typically expressed and purified for research applications?

  Recombinant Y. pestis nuoA is predominantly expressed using E. coli expression systems with N-terminal His-tag fusion for purification purposes . The general methodology involves:

  Expression Stage	Methodology
  Vector Construction	Cloning full-length nuoA (1-166 aa) into expression vectors like pET28a
  Expression Host	E. coli strains optimized for membrane protein expression
  Purification	Ni-NTA affinity chromatography targeting the His-tag
  Storage Form	Typically lyophilized with stabilizers (6% trehalose) in Tris/PBS buffer at pH 8.0
  Reconstitution	Rehydration in deionized water to 0.1-1.0 mg/mL with 5-50% glycerol for long-term storage

  Working aliquots should be stored at 4°C for up to one week, while long-term storage requires -20°C/-80°C conditions with minimal freeze-thaw cycles .

Advanced Research Questions

• How can omics approaches be applied to investigate nuoA's role in Y. pestis pathogenesis?

  Multiple omics strategies can be employed to elucidate nuoA's function in Y. pestis virulence:

  Omics Approach	Application to nuoA Research	Methodology
  Genomics	Evolutionary analysis of nuoA conservation across Yersinia species	Comparative genomic analysis with tools available in Yersiniomics platform
  Transcriptomics	Expression patterns under different infection conditions	RNA-Seq analysis of nuoA expression during host interaction
  Proteomics	Protein-protein interaction networks involving nuoA	Mass spectrometry-based interactome analysis
  Metabolomics	Impact of nuoA mutations on bacterial metabolism	Metabolic profiling of wild-type vs. nuoA mutants

  The Yersiniomics platform provides a centralized database gathering 200 genomic, 317 transcriptomic, and 62 proteomic datasets that can facilitate multi-omics integration for nuoA functional characterization . This integrated approach is particularly valuable since Y. pestis pathogenicity involves complex regulatory networks where respiratory components may play both metabolic and regulatory roles.

• What methodologies can be used to investigate potential contributions of nuoA to Y. pestis virulence?

  To determine if nuoA contributes to Y. pestis virulence, several experimental approaches should be considered:

  1. Targeted gene knockout: Generate ΔnuoA mutants using homologous recombination techniques similar to those used for other Y. pestis genes .

  2. Virulence assessment in animal models: Compare wild-type and ΔnuoA mutant strains in established mouse models of bubonic and pneumonic plague .

  3. Transcriptional response analysis: Evaluate how nuoA deletion affects expression of known virulence factors like F1 and LcrV under infection-relevant conditions .

  4. Metabolic profiling: Assess how nuoA disruption impacts bacterial survival under various environmental stresses encountered during infection.

  5. Comparative analysis with related species: Examine functional differences in nuoA between Y. pestis and its evolutionary ancestor Y. pseudotuberculosis to identify adaptations related to plague virulence .

  Recent studies on Y. pestis negative selection provide methodological templates that could be applied to nuoA functional analysis .

• How might nuoA function in the context of Y. pestis evolution from Y. pseudotuberculosis?

  Y. pestis evolved from Y. pseudotuberculosis within the past 20,000 years , acquiring specific adaptations that enabled its distinctive life cycle and virulence profile. Analysis of nuoA in this evolutionary context should consider:

  1. Sequence conservation analysis between Y. pestis and Y. pseudotuberculosis nuoA orthologs

  2. Functional comparison of respiratory metabolism between species under flea vector versus mammalian host conditions

  3. Assessment of selection pressure on nuoA during Y. pestis evolution (positive, negative, or neutral)

  4. Examination of nuoA expression patterns in different Y. pestis biovars and lineages associated with historical plague pandemics

  Evolutionary studies have identified other genes under negative selection during Y. pestis evolution that affected biofilm formation and vector adaptation . Similar approaches could reveal whether nuoA has undergone functional modifications contributing to Y. pestis' unique pathogenicity profile.

• What is the potential significance of studying nuoA in the context of Y. pestis strain diversity?

  Y. pestis exhibits significant strain diversity associated with different geographical foci and historical plague epidemics . Research on nuoA across this diversity spectrum could:

  1. Identify strain-specific variations in nuoA sequence or expression that correlate with virulence differences

  2. Examine nuoA conservation across ancient and modern strains, including those from the three major plague pandemics:

     • Justinian plague (541-750/767 CE)

     • Black Death pandemic (14th century)

     • Modern pandemic (late 19th-early 20th century)

  3. Compare respiratory metabolism adaptations in strains from different geographical plague foci

  4. Assess whether nuoA function varies between strains causing different plague manifestations (bubonic vs. pneumonic)

  Recent genomic characterization of Y. pestis strains from the 2017 Madagascar pneumonic plague outbreak demonstrated how multiple lineages can cause simultaneous epidemics , highlighting the importance of studying metabolic proteins like nuoA across diverse strains.

• How can protein interaction studies of nuoA contribute to understanding Y. pestis pathogenesis?

  Protein interaction studies focused on nuoA could reveal unexpected connections between metabolism and virulence in Y. pestis:

  1. Interactome analysis: Identify nuoA protein-protein interactions using pull-down assays coupled with mass spectrometry

  2. Bacterial two-hybrid screening: Discover potential regulatory interactions between nuoA and virulence-associated proteins

  3. Protein localization studies: Determine whether nuoA localizes exclusively to the membrane or forms additional associations during infection

  4. Temporal interaction dynamics: Examine how nuoA interactions change under various environmental conditions relevant to the plague transmission cycle

  Omics strategies previously applied to Y. pestis virulence research provide methodological frameworks that could be extended to nuoA-specific interaction studies . These approaches could reveal whether nuoA functions beyond its canonical role in respiration during host-pathogen interactions.

Research Applications

• Could nuoA potentially serve as a novel target for antimicrobial development against Y. pestis?

  While F1 and LcrV antigens have been the primary focus of plague vaccine development , respiratory chain components like nuoA offer potential alternative targets for therapeutic intervention:

  1. Target validation: Assess nuoA essentiality for Y. pestis survival under various conditions using conditional mutants

  2. Compound screening: Develop high-throughput assays to identify inhibitors specific to Y. pestis NDH-1 complex

  3. Structure-based drug design: Use recombinant nuoA structural information to design targeted inhibitors

  4. Adjunctive therapy potential: Evaluate respiratory chain inhibitors as adjuncts to conventional antibiotics for enhanced plague treatment

  The emergence of antibiotic-resistant Y. pestis strains necessitates exploration of alternative therapeutic targets, making metabolic enzymes like nuoA worthy of investigation despite the current focus on traditional virulence factors .

• What are the key considerations for designing experiments to study nuoA function in different stages of Y. pestis infection?

  Y. pestis encounters dramatically different environments during its transmission cycle between fleas and mammals. Experimental design for nuoA functional studies should account for these transitions:

  Infection Stage	Experimental Considerations	Methodological Approach
  Flea vector phase	Low temperature (22-30°C), blood meal environment	In vitro biofilm formation assays at flea-relevant temperatures
  Mammalian infection initiation	Temperature shift to 37°C, innate immune exposure	Human/mouse macrophage infection models
  Bubonic phase	Lymphatic system, neutrophil response	Murine bubonic plague model measuring lymph node bacterial load
  Pneumonic phase	Aerosol exposure, pulmonary environment	Inhalation challenge model in appropriate animal systems

  Considering Y. pestis' ability to cause different disease forms (bubonic, septicemic, and pneumonic plague) , it's essential to evaluate nuoA's role across these distinct infection scenarios, potentially revealing stage-specific functions or regulatory patterns.

Technical Considerations

• What quality control metrics should be applied when working with recombinant Y. pestis nuoA?

  Ensuring recombinant nuoA quality is critical for reliable experimental results. Standard quality control procedures should include:

  1. Purity assessment: >90% purity by SDS-PAGE analysis

  2. Functionality verification: Biochemical assays confirming NADH oxidation activity

  3. Structural integrity validation: Circular dichroism spectroscopy to confirm proper protein folding

  4. Endotoxin testing: LAL assay to ensure preparations are endotoxin-free for immunological studies

  5. Stability monitoring: Regular verification of protein stability during storage using activity assays

  For membrane proteins like nuoA, additional considerations include proper solubilization conditions and verification of membrane insertion in reconstitution experiments. Appropriate detergent selection is critical for maintaining functional integrity during purification and storage .

• How can researchers effectively integrate nuoA studies into broader Y. pestis systems biology approaches?

  Effective integration of nuoA-focused research into systems-level understanding of Y. pestis requires:

  1. Data standardization: Ensure compatibility with existing Yersiniomics databases by following standardized protocols and data formats

  2. Multi-scale modeling: Incorporate nuoA functional data into metabolic models of Y. pestis pathogenesis

  3. Comparative analysis: Systematically compare nuoA function across diverse Y. pestis strains and related Yersinia species

  4. Temporal profiling: Capture dynamic changes in nuoA expression and interaction networks throughout infection stages

  5. Integration with virulence models: Connect nuoA function to established virulence mechanisms like Type III secretion system activity

  The Yersiniomics platform provides valuable resources for such integration, allowing researchers to contextualize nuoA-specific findings within the broader landscape of Y. pestis biology and pathogenesis .